Nom du produit:tert-butyl ((1R,3R,4R)-3-amino-4-hydroxycyclopentyl)carbamate
IUPAC Name:tert-butyl N-[(1R,3R,4R)-3-amino-4-hydroxycyclopentyl]carbamate
- CAS：2408937-15-3
- Formule moléculaire：C10H20N2O3
- Pureté：95%+
- Numéro de catalogue：CM1078118
- Poids moléculaire：216.28
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2408937-15-3
- Formule moléculaire:C10H20N2O3
- Point de fusion:-
- Code SMILES:N(C(OC(C)(C)C)=O)[C@@H]1C[C@@H](N)[C@H](O)C1
- Densité:1.13±0.1 g/cm3
- Numéro de catalogue:CM1078118
- Poids moléculaire:216.28
- Point d'ébullition:354.9±42.0 °C
- N° Mdl:
- Stockage:
Category Infos
- Cyclopentanes
- Cyclopentane is a cycloalkane, an organic compound with a molecular formula of C5H10, a colorless and transparent liquid, insoluble in water, soluble in most organic solvents such as ethanol, ether, benzene, carbon tetrachloride, acetone, etc. It is mainly used as a solvent and chromatographic reference materials.
- Cyclopentanes,where to buy Cyclopentanes
- Cyclopentanes
- Cyclopentane (also called C pentane) is a highly flammable alicyclic hydrocarbon with chemical formula C5H10 and CAS number 287-92-3, consisting of a ring of five carbon atoms each bonded with two hydrogen atoms above and below the plane. It occurs as a colorless liquid with a petrol-like odor.
Column Infos
- AZD0780
- AstraZeneca announced Phase I trial data for its PCSK9 inhibitor, AZD0780. AZD0780 is an oral small molecule PCSK9 inhibitor as a first-in-class therapy for patients with dyslipidemia that cannot be controlled by statins alone. PSCK9 is a well-known and validated target in lipid metabolism and inhibiting PSCK9 signalling has shown to be effective in reducing LDL cholesterol levels in plasma. Lower LDL-C levels are associated with a reduction in the risk of long-term cardiovascular disease and major cardiovascular events.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.
Recherche 
+86 21 5895 0110 
